Atlas Trials

This is a Phase 1 Study to Evaluate the Safety,Tolerability and Virology of CT P59 in Patients With Mild Symptoms of Symptoms of Coronavirus Disease (COVID-19)

Clinical trial NCT04593641 · COMPLETED

Trial details

NCT number
NCT04593641
Sponsor
Celltrion
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
SARS-CoV-2 Infection
Start date
2020-09-04
Primary completion
2020-10-26
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.